There are gender differences in the public perception of nanotechnology, biotechnology and advanced manufacturing and processing. Understanding these differences could be of relevance for the up-take of the results by businesses and consumers in the NMPB fields.
For example, biotechnologies related to health (new methods or devices for diagnostics…), blue biotechnology searching for bioactive molecules, and advanced materials and nanotechnologies for health care and energy applications. There is a need for better understanding of the risks associated with nanomaterials, advanced materials and biotechnologies, and the potential differences in the way women and men are affected.
Actions in the focus area of the circular economy will include research and innovation tackling the gap between potential solutions and their societal and industrial take-up and deployment; this could take into account the different roles of male and female individuals as consumers and producers.
The industrial eco-system to deliver nanotechnologies and material technologies to the customer and citizen also requires new strategies taking these technologies from the idea to the product. Topics implemented as cross-cutting Key Enabling Technology (KET) pilot activities will build on previous research and this is a key point at which gender can be taken into account through taking the KETs forward1.
Second-generation metal-on-metal (MoM) hip prostheses implants fail more in women
Second-generation metal-on-metal (MoM) hip prostheses are widely used for hip replacement, consisting of cobalt -chromium metal alloys. However, the devices fail through pathological inflammation, osteolysis, and/ or pseudotumor formation. Inflammation also results in increased angiogenesis which augments the pathological conditions of further inflammation and pseudotumors. Furthermore, hip implants fail more in women. Given that follicle stimulating hormone (FSH) is elevated in women receiving hip implants, FSH has been shown to promote increased angiogenesis. Joshua Jamison and Steven Wood are […] examining how angiogenesis and the inflammatory response may be the result of untoward interactions of FSH with endothelial cells exposed to MoM wear particles.
Source: Joshua Jamison & Steven Wood (2015). FSH Increases VCAM-1 in Endothelial Cells Exposed to Metal-on-Metal (MoM) Particles. In: 2015 FDA Science Forum. Emerging Technologies. p. 203
- 1. Source: H2020-AG-GENDER (2015), pp. 12-13